The Harvard Program in Therapeutic Science (HiTS) is an academic research and education program that advances the fundamental science underlying human diseases and drug discovery in order to improve patient care.
The program’s faculty, trainees, and staff study disease using innovative approaches that fuse laboratory investigation, clinical research and computer science to accelerate the invention of life-saving medicines and the precision diagnostics needed to optimally treat individual patients. Our program brings together two approaches: Systems Pharmacology provides a powerful means to study the changes that promote disease and the ways in which therapeutic drugs function at a molecular level. Regulatory science focuses on the evaluation of drugs in clinical trials and on balancing the benefits and risks of new medicines.
Learn about our components:
Explore HiTS Research
News, Events, & Updates
Regulatory Science Open House
September 26, 12:00pm ET
HiTS Social Lunch
“Trivia and Lunch”
September 13, 2-1:30pm | ARM108
Regulatory Science Forum
“An Inflection Point for High-Quality Diagnostic Tests in Oncology”
Dr. Brian Alexander, CEO of Foundation Medicine
September 12, 12:00pm ET